Skip to main content

Together we are beating cancer

Donate now

Cancer News

Latest News

Showing 12 out of 6199 results
  • Science & Technology
  • Health & Medicine
  • For Researchers

Why people and culture matter in research

We bring you a summary of the government’s recent R&D People & Culture Strategy and what it could mean for cancer researchers We bring you a summary of the government’s recent R&D People & Culture Strategy and what it could mean for cancer researchers

by Cancer Research UK | Research Feature | 10 August 2021

10 August 2021

Clinician holds hand of patient on hospital bed.

Almost a third of cancer patients have reported receiving worse care since COVID-19 began, according to a new survey commissioned by Cancer Research UK. Almost a third of cancer patients have reported receiving worse care since COVID-19 began, according to a new survey commissioned by Cancer Research UK.

by Cancer Research UK | News | 5 August 2021

5 August 2021

The upcoming Early Detection of Cancer Conference brings together experts from multiple disciplines to share ground breaking research and progress in the field The upcoming Early Detection of Cancer Conference brings together experts from multiple disciplines to share ground breaking research and progress in the field

by Cancer Research UK | Research Feature | 4 August 2021

4 August 2021

  • Science & Technology
  • For Researchers

Embedding research integrity at the core of our science

Cancer Research UK has deepened its commitment to good research practice by becoming a signatory of the Concordat to support research integrity Cancer Research UK has deepened its commitment to good research practice by becoming a signatory of the Concordat to support research integrity

by Phil Prime | Research Feature | 28 July 2021

28 July 2021

Visualisation of the Cancer Revolution exhibit

We're proud to be the Expert Partners for ‘Cancer Revolution’, a cutting-edge, world-first exhibition about cancer that will open it's doors in Manchester and London. We're proud to be the Expert Partners for ‘Cancer Revolution’, a cutting-edge, world-first exhibition about cancer that will open it's doors in Manchester and London.

by Iain Foulkes | Opinion | 28 July 2021

28 July 2021

Lung cancer CT scan

1 in 2 people in the UK will be diagnosed with some form of cancer during their lifetime. We’ve estimated the impact different types of activity could make to ambitions to diagnose cancer earlier. 1 in 2 people in the UK will be diagnosed with some form of cancer during their lifetime. We’ve estimated the impact different types of activity could make to ambitions to diagnose cancer earlier.

by Hope Walters | Analysis | 27 July 2021

27 July 2021

A transgender woman in a hospital gown speaking to her doctor, a transgender man, in an exam room.

LGBTQIA+ communities experience inequalities throughout their cancer journey, including in screening and diagnosis, clinical care, communication and overall experience. Find out about the barriers the community faces and the commitments required to improve cancer care for LGBTQIA+ people. LGBTQIA+ communities experience inequalities throughout their cancer journey, including in screening and diagnosis, clinical care, communication and overall experience. Find out about the barriers the community faces and the commitments required to improve cancer care for LGBTQIA+ people.

by Harry Jenkins | Analysis | 26 July 2021

26 July 2021

Medical technologist holding urine tube test in medical laboratory

Cancer Research UK scientists are developing tests that can detect the presence of glioma, a type of brain tumour, in patient urine or blood plasma. Cancer Research UK scientists are developing tests that can detect the presence of glioma, a type of brain tumour, in patient urine or blood plasma.

by Cancer Research UK | News | 23 July 2021

23 July 2021

The National Institute of Health and Care Excellence (NICE) has approved the use of pemigatinib in adults with a rare type of bile duct cancer that has continued to advance or spread after initial chemotherapy. The National Institute of Health and Care Excellence (NICE) has approved the use of pemigatinib in adults with a rare type of bile duct cancer that has continued to advance or spread after initial chemotherapy.

by Harry Jenkins | News | 22 July 2021

22 July 2021